TrialInvestigational new drugs2012

Circulating thrombospondin 1 level as a surrogate marker in patients receiving cyclophosphamide-based metronomic chemotherapy.

Amélie Lansiaux et al.PubMed ↗Publisher ↗

No numbers read from the abstract.